Lv7
3400 积分 2020-12-06 加入
The next generation of antibody–drug conjugates
1个月前
已完结
Drugging the undruggable: Chemical and biological insights into molecular glues in the pipeline
1个月前
已完结
Phase I and pharmacokinetic study of the camptothecin analog DX-8951f administered as a 30-minute infusion every 3 weeks in patients with advanced cancer
1个月前
已完结
A phase I study of DX 8951f (exatecan mesylate for injection) in patients with renal dysfunction
1个月前
已关闭
A predictive model of human myelotoxicity using five camptothecin derivatives and the in vitro colony-forming unit granulocyte/macrophage assay
1个月前
已完结
Preclinical and Clinical Development of Exatecan (DX-951f)
1个月前
已完结
DX-8951f: summary of phase I clinical trials
1个月前
已完结
皖公网安备34019202002308
